United Therapeutics Corp · Brief

Next report

3 days

Nov 4 · before openest.Q3 FY26

Earnings

Expected move

Inputs

±4.1%implied · report alone

574.12623.32

straddle ±6.5%

spot 598.72exp Nov 20ATM strike 600ATM straddle 45.75IV 40%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

—≥ implied

Oct 30 '24—▲+2.44%—

Feb 26 '25—▼−10.80%—

Apr 30 '25—▲+0.77%—

Jul 30 '25—▼−5.25%—

Q3 FY25—▲+9.63%—

Q1 FY26—▲+13.03%—

May 6 '26—▲+4.29%—

Q2 FY26±6.1%▲+0.06%×0.01

quarterimplied−15%0+15%realized×

Q2 FY26±6.1%▲+0.06%×0.01

May '26—▲+4.29%—

Q1 FY26—▲+13.03%—

Q3 FY25—▲+9.63%—

Jul '25—▼−5.25%—

Apr '25—▲+0.77%—

2 older reports

Feb '25—▼−10.80%—

Oct '24—▲+2.44%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

—

Linked exposure

UTHR report session

Suppliers 1

MNKDMannKind Corporation ( MannKind )×0.44

× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 29impliedImplied move: ±6.0% into Nov 4 earnings (Oct 29 close).Source

Oct 21impliedImplied move: ±6.7% into Oct 28 earnings (Oct 21 close).Source

Oct 19impliedImplied move: ±7.3% into Nov 2 earnings (Oct 19 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.